Drawing for DELCETRAVIR

USPTO serial 79331699

DELCETRAVIR

Reviewed by CopyMark Law Group

Reg. 7307186Status 700Registered
Filing date
Status date
Registration date
Feb 20, 2024
Examiner
GARDNER, DAWNA BERYL
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with DELCETRAVIR?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Alana M. Fuierer

Alana M. Fuierer Heslin Rothenberg Farley & Mesiti P.C.5 Columbia CircleAlbany, NY 12203UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical, medicinal and therapeutic medicinal preparations for human and animal use, all for human and animal use for the treatment or prevention of infectious disease including but not limited to COVID-19 and coronaviruses; pharmaceutical preparations for the treatment or prevention of infectious disease including but not limited to COVID-19 and coronaviruses; pharmaceutical preparations for treatment or prevention of COVID-19, coronavirus disease, and respiratory diseases and disorders; veterinary preparations for the treatment or prevention of infectious disease including but not limited to COVID-19 and coronaviruses; veterinary pharmaceutical preparations for treatment or prevention of infectious diseases including but not limited to respiratory diseases and disordersACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Nov 1, 2024NREPNEW REPRESENTATIVE AT IB RECEIVED—
Jul 27, 2024FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Jul 6, 2024FICSFINAL DISPOSITION NOTICE SENT TO IB—
Jul 5, 2024FIMPFINAL DISPOSITION PROCESSED—
May 21, 2024FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
May 21, 2024FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Feb 20, 2024NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Feb 20, 2024R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Dec 5, 2023NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Dec 5, 2023PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Dec 3, 2023GPNXNOTIFICATION PROCESSED BY IB—
Nov 15, 2023OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Nov 15, 2023OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Nov 15, 2023NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Oct 31, 2023CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jul 21, 2023OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Jun 28, 2023OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Jun 27, 2023OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Dec 6, 2022TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Dec 6, 2022CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Dec 6, 2022TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 19, 2022RFNTREFUSAL PROCESSED BY IB—
Jul 7, 2022DOCKASSIGNED TO EXAMINER—
Jun 30, 2022RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Jun 30, 2022RFRRREFUSAL PROCESSED BY MPU—
Jun 28, 2022RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Jun 27, 2022CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 22, 2022DOCKASSIGNED TO EXAMINER—
Feb 1, 2022MAFRAPPLICATION FILING RECEIPT MAILED—
Jan 28, 2022NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jan 27, 2022REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance